What are the administration guidelines and potential side effects of Naltrexone (po) (oral) medication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Naltrexone (PO) Administration Guidelines and Side Effects

Oral naltrexone should be held for 2-3 days prior to elective surgical procedures if opioids are expected to be used perioperatively, due to its opioid antagonist properties that can block analgesic effects and potentially precipitate withdrawal. 1

Administration Guidelines

  • Naltrexone is a semisynthetic competitive opioid receptor antagonist with a plasma half-life of 4 hours, while its active metabolite (6-β-naltrexol) has a half-life of 13 hours 1
  • For alcohol dependence treatment, the standard dosage is 50 mg once daily 2
  • Initial dosing may start with 25 mg on the first day, then increase to 50 mg daily to improve tolerability 3
  • Patients must be completely opioid-free for 7-10 days before starting naltrexone to avoid precipitating withdrawal symptoms 2, 3
  • For patients with moderate to severe hepatic impairment, dose adjustments may be necessary due to increased naltrexone AUC (approximately 5-10 fold in patients with liver cirrhosis) 2
  • Renal impairment requires caution as naltrexone and its primary metabolite are excreted primarily in the urine 2

Perioperative Considerations

  • Hold oral naltrexone for 2-3 days prior to elective surgical procedures if opioids are expected to be used perioperatively 1
  • For extended-release injectable naltrexone, hold for 24-30 days after the last injection before elective surgical procedures 1
  • Patients on naltrexone may require higher doses of opioids for effective analgesia in emergency situations, with increased risk of respiratory depression 2
  • If naltrexone is used in combination with naloxone, monitor for symptoms of opioid withdrawal 1

Mechanism of Action

  • Naltrexone antagonizes mu (highest affinity), kappa, and delta opioid receptors 1
  • It prevents patients from experiencing the euphoric effects of narcotics and alcohol 1
  • May reset the reward pathway through an opponent process mechanism 1
  • When used for obesity treatment in combination with bupropion, naltrexone antagonizes an inhibitory feedback loop that would otherwise limit bupropion's anorectic properties 1

Side Effects

Common Side Effects (>2% incidence):

  • Nausea (10%) 2
  • Headache (7%) 2
  • Dizziness (4%) 2
  • Nervousness/anxiety (4%) 2
  • Fatigue (4%) 2
  • Insomnia (3%) 2
  • Vomiting (3%) 2
  • Abdominal pain/cramps 2
  • Joint and muscle pain 2

Less Common Side Effects (<2% incidence):

  • Loss of appetite, diarrhea, constipation 2
  • Increased thirst, irritability 2
  • Skin rash 2
  • Sexual dysfunction (delayed ejaculation, decreased potency) 2
  • Respiratory symptoms (nasal congestion, rhinorrhea, sore throat) 2

Serious Adverse Effects:

  • Hepatotoxicity at doses higher than the standard 50 mg daily dose 2, 4
  • Depression and suicidal ideation have been reported, though causal relationship is not established 2
  • False-positive opioid (specifically oxycodone) urine drug screens due to the naltrexone metabolite noroxymorphone 5

Special Precautions

  • Patients should carry identification indicating they are taking naltrexone 2
  • Naltrexone blocks the effects of opioids, so patients will not experience pain relief from opioid medications 2
  • Monitor liver function before and during treatment 3
  • Avoid use in pregnant women, breastfeeding women, and patients under 18 years of age 3
  • Patients with a history of depression should be monitored closely for mood changes 2
  • Naltrexone is most effective when used as part of a comprehensive treatment program that includes counseling and support 2, 4

Clinical Efficacy

  • Meta-analyses have shown oral naltrexone is effective in reducing relapse to heavy drinking but less effective in enhancing abstinence 6
  • The effect size for alcohol dependence treatment is modest (0.15-0.2 range) 6
  • Long-acting injectable naltrexone has shown a 25% decrease in heavy drinking days compared to placebo 7
  • Naltrexone is valuable as supplementary therapy for maintaining abstinence in previously opioid-dependent individuals 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.